Skip to main content
SpringerLink
Log in

Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined with Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma: The SIROCHO Trial Design

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663–73. https://doi.org/10.1016/S1470-2045(18)30915-X.

    Article  CAS  Google Scholar 

  2. Yadav S, Xie H, Bin-Riaz I, et al. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: a propensity score matched analysis. Eur J Surg Oncol. 2019;45(8):1432–8. https://doi.org/10.1016/j.ejso.2019.03.023.

    Article  Google Scholar 

  3. Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2015;22(12):4020–8.

    Article  Google Scholar 

  4. Edeline J, Touchefeu Y, Guiu B, et al. Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2020;6(1):51. https://doi.org/10.1001/jamaoncol.2019.3702.

    Article  Google Scholar 

  5. Rayar M, Sulpice L, Edeline J, et al. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Ann Surg Oncol. 2015;22(9):3102–8. https://doi.org/10.1245/s10434-014-4365-3.

    Article  CAS  Google Scholar 

  6. Riby D, Mazzotta AD, Bergeat D, et al. Downstaging with radioembolization or chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2020;27(10):3729–37. https://doi.org/10.1245/s10434-020-08486-7.

    Article  Google Scholar 

Download references

Acknowledgement

This study was funded by French governmental funding (PHRC-K 2020) and the microspheres were provided by Boston Scientific.

Author information

Authors and Affiliations

  1. Medical Oncology, Centre Eugène Marquis, av bataille Flandres-Dunkerque, 35042, Rennes, France

    Julien Edeline MD, PhD & Héloïse Bourien MD

  2. Interventional Radiology, Centre Eugène Marquis, Rennes, France

    Yan Rolland MD, PhD

  3. Data Research Unit, Centre Eugène Marquis, Rennes, France

    Boris Campillo-Gimenez MD

  4. Clinical Research Support Unit, Centre Eugène Marquis, Rennes, France

    Marion Trochet PhD

  5. Nuclear Medicine, Centre Eugène Marquis, Rennes, France

    Etienne Garin MD, PhD

  6. Hepatobiliary Surgery, CHU Pontchaillou, Rennes, France

    Karim Boudjema MD, PhD

Authors
  1. Julien Edeline MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Rolland MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Boris Campillo-Gimenez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Héloïse Bourien MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marion Trochet PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Etienne Garin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Karim Boudjema MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julien Edeline MD, PhD.

Ethics declarations

Disclosures

Julien Edeline, Yan Rolland, and Etienne Garin report honoraria from Boston Scientific. Julien Edeline and Etienne Garin report research funding from Boston Scientific. Boris Campillo-Gimenez, Héloïse Bourien, Marion Trochet, and Karim Boudjema have no conflicts of interest to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edeline, J., Rolland, Y., Campillo-Gimenez, B. et al. Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined with Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma: The SIROCHO Trial Design. Ann Surg Oncol 30, 21–22 (2023). https://doi.org/10.1245/s10434-022-12708-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12708-5

Search

Navigation